Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12221462
Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells
granted -
US 12221622
Modified pluripotent cells
granted -
US 12220595
Stem cell rich plasma compositions and uses thereof for treating aging subjects
granted -
US 12221414
Quaternary ammonium salt compound, preparation method therefor and use thereof
granted -
US 12220455
Coronavirus vaccine compositions and methods
granted -
US 12220420
Combination therapy for cancer treatment
granted -
US 12220389
Combination therapy for the treatment of tinnitus and other medical conditions
granted -
US 12221627
Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
granted -
US 12220453
Compositions and treatments for Haemophilus influenzae
granted -
US 12220421
Inhibitors of C. difficile spore germination
granted -
US 12220409
Roflumilast formulations with an improved pharmacokinetic profile
granted -
US 12221607
Multi-targeted single entity conjugates
granted -
US 12220424
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 12221612
Plants having increased oil quality
granted -
US 12221629
Methods for producing fibroadipogenic progenitor cells
granted -
US 12221610
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use
granted -
US 12222355
Therapeutic antibodies against ROR-1 protein and methods for use of same
granted -
US 12221422
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
granted -
US 12221463
Method of promoting wound healing by inhibiting CCR3
granted -
US 12223643
Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted -
WO 2025027051
INHIBITEURS DE SPHINGOSINE-1-PHOSPHATE LYASE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
granted -
WO 2025027551
VACCIN ANTI-IBV AVEC PROTÉINE DE SPICULE DE DMV/1639 HÉTÉROLOGUE
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.